Par Drugs and Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	1,064	1,010	956.4	957.49	750.74	607.51
Revenue	1,064	1,010	956.4	957.49	750.74	607.51
Revenue Growth (YoY)	4.84%	5.58%	-0.11%	27.54%	23.58%	8.78%
Cost of Revenue	452.87	391.87	346.53	409.83	293.18	224.99
Gross Profit	610.87	617.86	609.88	547.65	457.57	382.53
Selling, General & Admin	60.95	58.52	54.99	48.88	41.01	39.78
Other Operating Expenses	368.66	364.24	326.71	316.7	254.01	182.61
Operating Expenses	466.56	459.23	416.06	397.91	327.83	250.59
Operating Income	144.31	158.64	193.81	149.74	129.74	131.94
Interest Expense	-0.23	-	-	-0.02	-3.77	-6.03
Interest & Investment Income	10.81	10.81	2.32	0.72	1.84	1.32
Other Non Operating Income (Expenses)	21.99	-0.82	-1.07	-1.31	-0.78	0.17
EBT Excluding Unusual Items	176.88	168.62	195.07	149.13	127.03	127.39
Gain (Loss) on Sale of Investments	10.61	10.61	0.02	-	-	-
Gain (Loss) on Sale of Assets	-	-	0.08	1.43	-	0
Other Unusual Items	-	-	-	-	-	19.86
Pretax Income	187.49	179.23	195.17	150.79	127.03	147.26
Income Tax Expense	48.43	45.65	50.16	37.45	34.9	31.15
Net Income	139.06	133.58	145.01	113.34	92.13	116.11
Net Income to Common	139.06	133.58	145.01	113.34	92.13	116.11
Net Income Growth	-9.86%	-7.88%	27.94%	23.02%	-20.65%	143.68%
Shares Outstanding (Basic)	12	12	12	12	12	12
Shares Outstanding (Diluted)	12	12	12	12	12	12
Shares Change (YoY)	-0.05%	-	-	-	-	-
EPS (Basic)	11.31	10.86	11.78	9.21	7.49	9.44
EPS (Diluted)	11.31	10.86	11.78	9.21	7.49	9.44
EPS Growth	-9.77%	-7.84%	27.90%	23.00%	-20.64%	143.64%
Free Cash Flow	-	149.34	141.69	57.43	44.13	70.36
Free Cash Flow Per Share	-	12.14	11.52	4.67	3.59	5.72
Dividend Per Share	-	-	-	-	1.250	-
Gross Margin	57.43%	61.19%	63.77%	57.20%	60.95%	62.97%
Operating Margin	13.57%	15.71%	20.27%	15.64%	17.28%	21.72%
Profit Margin	13.07%	13.23%	15.16%	11.84%	12.27%	19.11%
Free Cash Flow Margin	-	14.79%	14.81%	6.00%	5.88%	11.58%
EBITDA	182.35	195.1	228.17	182.07	162.55	160.13
EBITDA Margin	17.14%	19.32%	23.86%	19.02%	21.65%	26.36%
D&A For EBITDA	38.04	36.47	34.36	32.33	32.81	28.19
EBIT	144.31	158.64	193.81	149.74	129.74	131.94
EBIT Margin	13.57%	15.71%	20.27%	15.64%	17.28%	21.72%
Effective Tax Rate	25.83%	25.47%	25.70%	24.84%	27.47%	21.15%
Revenue as Reported	1,108	1,031	958.83	959.87	752.58	609.41

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.